PLoS ONE (Jan 2014)

Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.

  • Chuan Wang,
  • Jun Song,
  • Zeqiang Ma,
  • Weifang Yang,
  • Chengqiao Li,
  • Xiuping Zhang,
  • Xinguo Hou,
  • Yu Sun,
  • Peng Lin,
  • Kai Liang,
  • Lei Gong,
  • Meijian Wang,
  • Fuqiang Liu,
  • Wenjuan Li,
  • Fei Yan,
  • Junpeng Yang,
  • Lingshu Wang,
  • Meng Tian,
  • Jidong Liu,
  • Ruxing Zhao,
  • Li Chen

DOI
https://doi.org/10.1371/journal.pone.0102941
Journal volume & issue
Vol. 9, no. 7
p. e102941

Abstract

Read online

ObjectiveTo investigate how the glucose variability between fasting and a 2-h postload glucose state (2-h postload plasma glucose [2hPG]-fasting plasma glucose [FPG]) is associated with chronic kidney disease (CKD) in middle-aged and elderly Chinese patients previously diagnosed with type 2 diabetes.Design and methodsThis cross-sectional study included 1054 previously diagnosed type 2 diabetes patients who were 40 years of age and older. First, the subjects were divided into two groups based on a glycated hemoglobin (HbA1c) value of 7%. Each group was divided into two subgroups, with or without CKD. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to estimate the glomerular filtration rate (GFR). CKD was defined as eGFRResultsIn the patients with HbA1c levels ≥7%, the 2hPG-FPG was significantly associated with decreased eGFR and an increased risk of CKD independent of age, gender, body mass index (BMI), systolic blood pressure (BP), diastolic BP, smoking, and drinking, as well as fasting insulin, cholesterol, triglyceride, and HbA1c levels. The patients with 2hPG-FPG values ≥144 mg/dl showed an increased odds ratio (OR) of 2.640 (P = 0.033). Additionally, HbA1c was associated with an increased risk of CKD in patients with HbA1c values ≥7%.ConclusionsThe short-term glucose variability expressed by 2hPG-FPG is closely associated with decreased eGFR and an increased risk of CKD in patients with poor glycemic control (HbA1c≥7%).